Not admitted · Not a forecast
Rules 1.1.0 · as of 14 Sep 2026
Rick Doblin · Said 14 Jan 2019 · doblin-0246
Quote
Not a forecast
“Considering that tens of millions of people have been taking MDMA for more than 40 years, we already know the risk profile very well. So, the key factor is whether we obtain statistically significant results.”
Doblin says the only real question for the first Phase 3 trial is whether it reaches statistical significance, because safety is already known.
Descriptive, retrospective, or a statement of preference; no future state asserted.